InsidersTradesSigma
HERON THERAPEUTICS, INC. /DE/ Stock: price and management transactions · United States · SEC (Form 4)
Follow the HERON THERAPEUTICS, INC. /DE/ share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €93.9m. The latest transaction was filed on 3 August 2026 (Levée d'options). Among the most active insiders: Duarte Ira. All data is free.
126
Insider Decl.
n/a
Thresholds
€9m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,208 of 28,169 companies
28.9
score / 100
Value9
Quality49
FCF yld-30%
Earn yld-22%
EV/EBITDA·
ROE·
Gross mgn73%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 August 2026
Declarations126 total
50,021 sharesCommon StockSEC:0001193125-26-329694:0
34,789 sharesCommon StockSEC:0001193125-26-329694:1
13,535 sharesCommon StockSEC:0001193125-26-329720:0
3,850 shares@ US$0.50Common StockSEC:0001193125-26-329720:1
11,694 sharesCommon StockSEC:0001193125-26-329720:2
3,326 shares@ US$0.50Common StockSEC:0001193125-26-329720:3
11,769 sharesCommon StockSEC:0001193125-26-329804:0
3,348 shares@ US$0.50Common StockSEC:0001193125-26-329804:1
11,694 sharesCommon StockSEC:0001193125-26-329804:2
3,326 shares@ US$0.50Common StockSEC:0001193125-26-329804:3
11,769 sharesCommon StockSEC:0001193125-26-329848:0
13,797 sharesCommon StockSEC:0001193125-26-308958:0
3,874 sharesCommon StockSEC:0001193125-26-308922:0
3,874 sharesCommon StockSEC:0001193125-26-308887:0
1,101 shares@ US$0.470.0006% mcap0.6% of flowCommon StockSEC:0001193125-26-308887:1
1,101 shares@ US$0.470.0006% mcap0.7% of flowCommon StockSEC:0001193125-26-308922:1
12,500 sharesCommon StockSEC:0001193125-26-273552:0
3,555 sharesCommon StockSEC:0001193125-26-273552:1
13,797 sharesCommon StockSEC:0001193125-26-165365:0
3,874 sharesCommon StockSEC:0001193125-26-165304:0
3,874 sharesCommon StockSEC:0001193125-26-165591:0
62,500 sharesCommon StockSEC:0001193125-26-144196:0
53,960 shares0Common StockSEC:0001193125-26-034632:0
53,960 shares0Common StockSEC:0001193125-26-034631:0
53,960 shares0Common StockSEC:0001193125-26-034629:0
25 of 126 declarations
About HERON THERAPEUTICS, INC. /DE/
HERON THERAPEUTICS, INC. is a biopharmaceutical company focused on developing treatments for pain and nausea. It is listed on NASDAQ under the ticker HRTX.